{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:25:55Z","timestamp":1792596355621,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["021397"],"award-info":[{"award-number":["021397"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["112812"],"award-info":[{"award-number":["112812"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["130239"],"award-info":[{"award-number":["130239"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["SNF P400PB_186728"],"award-info":[{"award-number":["SNF P400PB_186728"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.molmet.2023.101743","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T02:37:22Z","timestamp":1685068642000},"page":"101743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["GIP receptor agonism blocks chemotherapy-induced nausea and vomiting"],"prefix":"10.1016","volume":"73","author":[{"given":"Tito","family":"Borner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Crist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Daniel","family":"Furst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Doebley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia G.","family":"Halas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minrong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo J.","family":"Samms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2023.101743_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3389\/fphar.2018.00913","article-title":"A\u00a0history of drug discovery for treatment of nausea and vomiting and the implications for future research","volume":"9","author":"Sanger","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.molmet.2023.101743_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41395-018-0039-2","article-title":"Chronic nausea and vomiting: evaluation and treatment","volume":"113","author":"Lacy","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.molmet.2023.101743_bib3","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra0706547","article-title":"Chemotherapy-induced nausea and vomiting","volume":"358","author":"Hesketh","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.molmet.2023.101743_bib4","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","volume":"29","author":"Basch","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.molmet.2023.101743_bib5","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.20230","article-title":"Incidence of chemotherapy-induced nausea and emesis after modern antiemetics","volume":"100","author":"Grunberg","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.molmet.2023.101743_bib6","article-title":"Nausea and vomiting in people with cancer and other chronic diseases","volume":"2009","author":"Keeley","year":"2009","journal-title":"Clin Evid"},{"key":"10.1016\/j.molmet.2023.101743_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-410473-0.00012-X","article-title":"Cisplatin-induced anorexia and ghrelin","volume":"92","author":"Hattori","year":"2013","journal-title":"Vitam Horm"},{"key":"10.1016\/j.molmet.2023.101743_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2012.06.015","article-title":"Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance","volume":"16","author":"Grill","year":"2012","journal-title":"Cell Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/frne.1994.1012","article-title":"The area postrema and vomiting","volume":"15","author":"Miller","year":"1994","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.molmet.2023.101743_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2013.08.047","article-title":"The role of vagal neurocircuits in the regulation of nausea and vomiting","volume":"722","author":"Babic","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2023.101743_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cmet.2019.12.004","article-title":"GDF15 induces anorexia through nausea and emesis","volume":"31","author":"Borner","year":"2020","journal-title":"Cell Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuron.2020.11.010","article-title":"Area postrema cell types that mediate nausea-associated behaviors","volume":"109","author":"Zhang","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.molmet.2023.101743_bib13","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2337\/db21-0459","article-title":"GIP receptor agonism attenuates GLP-1 receptor agonist-induced nausea and emesis in preclinical models","volume":"70","author":"Borner","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2023.101743_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s42255-021-00363-1","article-title":"A genetic map of the mouse dorsal vagal complex and its role in obesity","volume":"3","author":"Ludwig","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2023.101743_bib15","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2023.101743_bib16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1210\/jcem-37-5-826","article-title":"Stimulation of insulin secretion by gastric inhibitory polypeptide in man","volume":"37","author":"Dupre","year":"1973","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2023.101743_bib17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1210\/edrv-16-3-390","article-title":"Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide","volume":"16","author":"Fehmann","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.molmet.2023.101743_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"Muller","year":"2019","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat3392","article-title":"Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models","volume":"10","author":"Killion","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.molmet.2023.101743_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/dom.13034","article-title":"A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents","volume":"20","author":"Norregaard","year":"2018","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cmet.2017.07.011","article-title":"The sustained effects of a dual GIP\/GLP-1 receptor agonist, NNC0090-2746, in patients with type 2 diabetes","volume":"26","author":"Frias","year":"2017","journal-title":"Cell Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib23","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2023.101743_bib24","doi-asserted-by":"crossref","first-page":"209ra151","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans","volume":"5","author":"Finan","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.molmet.2023.101743_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13300-020-00981-0","article-title":"The role of tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes: the SURPASS clinical trials","volume":"12","author":"Min","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.molmet.2023.101743_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/17446651.2020.1830759","article-title":"A\u00a0glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes","volume":"15","author":"Frias","year":"2020","journal-title":"Expet Rev Endocrinol Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/dom.13979","volume":"22","author":"Frias","year":"2020","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib28","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2337\/db21-0848","article-title":"GIPR agonism inhibits PYY-induced nausea-like behavior","volume":"71","author":"Samms","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2023.101743_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.autneu.2006.01.008","article-title":"Signals for nausea and emesis: implications for models of upper gastrointestinal diseases","volume":"125","author":"Andrews","year":"2006","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.molmet.2023.101743_bib30","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/dom.14089","article-title":"A second-generation glucagon-like peptide-1 receptor agonist mitigates vomiting and anorexia while retaining glucoregulatory potency in lean diabetic and emetic mammalian models","volume":"22","author":"Borner","year":"2020","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib31","doi-asserted-by":"crossref","first-page":"107768","DOI":"10.1016\/j.celrep.2020.107768","article-title":"Corrination of a GLP-1 receptor agonist for glycemic control without emesis","volume":"31","author":"Borner","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.molmet.2023.101743_bib32","doi-asserted-by":"crossref","first-page":"101422","DOI":"10.1016\/j.molmet.2021.101422","article-title":"Single nuclei RNA sequencing of the rat AP and NTS following GDF15 treatment","volume":"56","author":"Reiner","year":"2022","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41398-022-02135-1","article-title":"Single nucleus transcriptomic analysis of rat nucleus accumbens reveals cell type-specific patterns of gene expression associated with volitional morphine intake","volume":"12","author":"Reiner","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.molmet.2023.101743_bib34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","article-title":"Single-cell transcriptomic analysis of Alzheimer\u2019s disease","volume":"570","author":"Mathys","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2023.101743_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41593-020-0621-y","article-title":"Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons","author":"Nagy","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.molmet.2023.101743_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","article-title":"Neuronal vulnerability and multilineage diversity in multiple sclerosis","volume":"573","author":"Schirmer","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2023.101743_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1126\/science.aav8130","article-title":"Single-cell genomics identifies cell type-specific molecular changes in autism","volume":"364","author":"Velmeshev","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.molmet.2023.101743_bib38","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/bioinformatics\/btaa751","article-title":"Systematic determination of the mitochondrial proportion in human and mice tissues for single-cell RNA-sequencing data quality control","volume":"37","author":"Osorio","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.molmet.2023.101743_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neures.2020.11.007","article-title":"Notch1 and Notch2 collaboratively maintain radial glial cells in mouse neurogenesis","volume":"170","author":"Mase","year":"2021","journal-title":"Neurosci Res"},{"key":"10.1016\/j.molmet.2023.101743_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cell.2015.09.004","article-title":"Molecular identity of human outer radial glia during cortical development","volume":"163","author":"Pollen","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molmet.2023.101743_bib41","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1038\/s41467-021-25960-2","article-title":"Confronting false discoveries in single-cell differential expression","volume":"12","author":"Squair","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2023.101743_bib42","doi-asserted-by":"crossref","first-page":"R902","DOI":"10.1152\/ajpregu.90952.2008","article-title":"Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus)","volume":"296","author":"De Jonghe","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.molmet.2023.101743_bib43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fnins.2011.00088","article-title":"Behavioral patterns associated with chemotherapy-induced emesis: a potential signature for nausea in musk shrews","volume":"5","author":"Horn","year":"2011","journal-title":"Front Neurosci"},{"key":"10.1016\/j.molmet.2023.101743_bib44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0024-3205(87)90229-3","article-title":"Suncus murinus: a new experimental model in emesis research","volume":"41","author":"Ueno","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.molmet.2023.101743_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1254\/jjp.48.303","article-title":"Emesis induced by cancer chemotherapeutic agents in the Suncus murinus: a new experimental model","volume":"48","author":"Matsuki","year":"1988","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.molmet.2023.101743_bib46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(03)01863-6","article-title":"Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew)","volume":"472","author":"Sam","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2023.101743_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/1c75cd5d-9dde-4ace-8524-a4980745e804","article-title":"Why can\u2019t rodents vomit? A comparative behavioral, anatomical, and physiological study","volume":"8","author":"Horn","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2023.101743_bib48","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0091-3057(93)90126-E","article-title":"Pica in rats is analogous to emesis: an animal model in emesis research","volume":"45","author":"Takeda","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.molmet.2023.101743_bib49","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0031-9384(76)90171-2","article-title":"Poison induced pica in rats","volume":"17","author":"Mitchell","year":"1976","journal-title":"Physiol Behav"},{"key":"10.1016\/j.molmet.2023.101743_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1358\/mf.2002.24.3.802297","article-title":"Pica in mice as a new model for the study of emesis","volume":"24","author":"Yamamoto","year":"2002","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.molmet.2023.101743_bib51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/annonc\/mdq600","article-title":"Update and new trends in antiemetic therapy: the continuing need for novel therapies","volume":"22","author":"Feyer","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.molmet.2023.101743_bib52","first-page":"2749","article-title":"A\u00a0qualitative study investigating chemotherapy-induced nausea as a symptom cluster","volume":"22","author":"Olver","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.molmet.2023.101743_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autneu.2006.07.009","article-title":"Treatment of nausea and vomiting: gaps in our knowledge","volume":"129","author":"Sanger","year":"2006","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.molmet.2023.101743_bib54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2023.101743_bib55","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmet.2020.10.023","article-title":"GDF-15 neutralization alleviates platinum-based chemotherapy-induced emesis, anorexia, and weight loss in mice and nonhuman primates","volume":"32","author":"Breen","year":"2020","journal-title":"Cell Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib56","doi-asserted-by":"crossref","first-page":"110953","DOI":"10.1016\/j.celrep.2022.110953","article-title":"A\u00a0brainstem circuit for nausea suppression","volume":"39","author":"Zhang","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.molmet.2023.101743_bib57","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","article-title":"Functional mapping and annotation of genetic associations with FUMA","volume":"8","author":"Watanabe","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2023.101743_bib58","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00221-014-3905-1","article-title":"Gabapentin's anti-nausea and anti-emetic effects: a review","volume":"232","author":"Guttuso","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.molmet.2023.101743_bib59","first-page":"13","article-title":"Review about gabapentin misuse, interactions, contraindications and side effects","volume":"9","author":"Quintero","year":"2017","journal-title":"J\u00a0Exp Pharmacol"},{"key":"10.1016\/j.molmet.2023.101743_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.molmet.2023.101743_bib61","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1139\/apnm-2013-0369","article-title":"Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment","volume":"39","author":"Chevalier","year":"2014","journal-title":"Appl Physiol Nutr Metabol"},{"key":"10.1016\/j.molmet.2023.101743_bib62","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1101\/gad.276733.115","article-title":"Mechanisms of metabolic dysfunction in cancer-associated cachexia","volume":"30","author":"Petruzzelli","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.molmet.2023.101743_bib63","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molmed.2016.03.005","article-title":"Reappraisal of GIP pharmacology for metabolic diseases","volume":"22","author":"Finan","year":"2016","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.molmet.2023.101743_bib64","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.tem.2020.02.006","article-title":"How may GIP enhance the therapeutic efficacy of GLP-1?","volume":"31","author":"Samms","year":"2020","journal-title":"Trends Endocrinol Metabol"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:35:50Z","timestamp":1761957350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877823000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":64,"alternative-id":["S2212877823000777"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101743","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GIP receptor agonism blocks chemotherapy-induced nausea and vomiting","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101743"}}